Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial

Simona Sica, Jorge E Cortes, Samer Khaled, Giovanni Martinelli, Alexander E Perl, Siddhartha Ganguly, Nigel Russell, Alwin Krämer, Hervé Dombret, Donna Hogge, Brian A Jonas, Anskar Yu-Hung Leung, Priyanka Mehta, Pau Montesinos, Markus Radsak, Meena Arunachalam, Melissa Holmes, Ken Kobayashi, Ruth Namuyinga, Nanxiang GeAntoine Yver, Yufen Zhang, Mark J Levis

Research output: Contribution to journalArticle

114 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences